21.12.2016 • News

Amyris and Nikkol in Cosmetic Ingredients Pact

(c) Jakub Pavlinec/Getty Image
(c) Jakub Pavlinec/Getty Image

US renewables company Amyris has signed an agreement with Japan’s Nikkol Group to form a cosmetic ingredients joint venture. Under the terms of the proposal, Nikkol will purchase 50% of Amyris’s Neossance squalane business for up to a total of $20 million. Amyris will receive half of the purchase price upfront and the remaining $10 million is structured as an earn-out over the first three years of the jv’s operation.

“This agreement is another key step among several in our stated plan to build greater value for our business and ensure access to partner-driven growth capital while positioning the company to significantly expand product sales,” said John Melo, president and CEO of Amyris.

The bioscience company expects sales of squalane – a high-performance emollient used in a variety of cosmetics and skincare products – to continue growing at above 50% annually, while the jv will cut its expenses by more than $1.5 million per year.

The prospective partners are already known to each other, as Nikkol has been distributing Amyris’ cosmetics ingredients in the Japanese market for several years. “By working together, we believe the additional financial, marketing, innovation and business development synergies will lead to a significant expansion in market applications,” commented Shizuo Ukaji, president and CEO of Nikko Chemicals, a Nikkol subisidary.

In separate news, Amyris is collaborating with the government of Queensland, Australia, to create a biotechnology hub that will serve the rapidly growing personal care sector in southeast Asia. The partners intend to develop a new manufacturing plant for Amyris’s personal care and nutraceutical actives as well as farnesene-based products.

The first industrial production at the Queensland plant is expected to start up in 2020. If this timing is achieved, the facility would generate annual revenue of $60-80 million, potentially paying back investors in two to three years.

In June, Amyris and the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland signed a Memorandum of Understanding to support the development of a Queensland-based biotechnology industry using feedstock from local sugarcane.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.